L. Budel

发表

Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma.

P. Sonneveld, B. van der Holt, B. Löwenberg, 2000, Haematologica.

Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.

B. Löwenberg, I. Touw, R. Delwel, 1990, Blood.

The influence of wire localisation for non-palpable breast lesions on visualisation of the sentinel node

J. E. Jansen, L. Quekel, G. Verberne, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

The expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin's lymphomas

P. Sonneveld, B. Löwenberg, R. Delwel, 2007, Leukemia & lymphoma.

Hematopoietic growth factor receptors: structure variations and alternatives of receptor complex formation in normal hematopoiesis and in hematopoietic disorders.

F. Dong, I. Touw, B. Löwenberg, 1995, Leukemia.

Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic stem cell transplantation

C. Boucher, B. van der Holt, J. Gratama, 2001, British journal of haematology.

Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa. A form of "traumatic eosinophilic granuloma".

L. Pan, B. Alobeid, G. Frizzera, 2004, American journal of clinical pathology.

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome

M. D. den Bakker, G. V. van Leenders, M. Kliffen, 2020, Virchows Archiv.

The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B‐cell lymphomas

P. Sonneveld, B. van der Holt, R. Delwel, 2011, European journal of haematology.

Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials.

D. de Jong, P. Sonneveld, B. van der Holt, 2011, Clinical lymphoma, myeloma & leukemia.

Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population

S. A. Dingemans, A. V. D. van der Pool, C. Contant, 2015, Annals of Surgical Oncology.

Asymmetrical fat embolism

A. Bartelink, E. Boon, L. Budel, 2001, The Lancet.

GM-CSF, IL-3 and G-CSF receptors on acute myeloid leukemia cells : function, regulation of expression, and ligand binding characteristics

L. Budel, 1993 .

High levels of serum prostate‐specific antigen due to PSA producing follicular non‐Hodgkin’s lymphoma

J. Oosterheert, P. Vos, S. Wittebol, 2007, European journal of haematology.

NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome

M. Roobol, M. D. den Bakker, C. Bangma, 2022, BJU international.

Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF.

H. Burger, G. Wagemaker, B. Löwenberg, 1994, Experimental hematology.

Increased sensitivity of B-cell clonality analysis in formalin-fixed and paraffin-embedded B-cell lymphoma samples using an enzyme blend with both 5′→3′ DNA polymerase and 3′→5′ exonuclease activity

W. Dinjens, E. Bagdi, L. Krenács, 2003, Virchows Archiv.

Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE)

M. Roobol, C. Bangma, M. Busstra, 2020, Histopathology.

Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

M Chilosi, M. Pagano, A. Montagnoli, 2000, Blood.

Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia.

T. Agthoven, R. V. van Gurp, T. V. van Agthoven, 1990, Blood.

Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.

B. Löwenberg, R. Delwel, H. Hoogerbrugge, 1993, Leukemia.

Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.

I. Touw, B. Löwenberg, I. Touw, 1991, The Journal of clinical investigation.

Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells.

I. Touw, B. Löwenberg, I. Touw, 1991, Blood.

Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells.

I. Touw, R. Delwel, H. Hoogerbrugge, 1991, Blood.